Nucleus plus
  • Patient Care
  • About
 
 

06.21.22

Complex Genomic Features Underlying CAR T-Cell Failures in Lymphoma

by ASTCT Science Highlights

Jain MD, Ziccheddu B, Coughlin CA, et al. Whole-Genome Sequencing Reveals Complex Genomic Features Underlying Anti-CD19 CAR T-Cell Treatment Failures in Lymphoma. Blood. 2022; (doi: 10.1182/blood.2021015008).

Tumor-intrinsic genomic changes appear to contribute significantly to treatment failure in persons with large B-cell lymphomas who undergo CD19-directed chimeric antigen receptor (CAR-19) therapy. Researchers used whole-genome sequencing to study 51 tumor samples from 49 individuals matching this patient profile. Reduced expression or loss of CD19 prior to treatment had no impact on responses, raising the probability that more than one mechanism is implicated in CAR-19 treatment success or failure. In fact, the analysis identified several predictors of CAR-19 resistance — including the presence of complex structural variants, certain mutational processes, and genomic damage from reactive oxygen species. Deletion of the RHOA tumor suppressor also was associated with CAR-19 clinical failure.

Read More

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
08.02.22
Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
by ASTCT Science Highlights
Single-Cell Antigen-Specific Landscape of CAR T Infusion Product Identifies Determinants of CD19-Positive Relapse in Patients with ALL
07.28.22
Single-Cell Antigen-Specific Landscape of CAR T Infusion Product Identifies Determinants of CD19-Positive Relapse in Patients with ALL
by ASTCT Science Highlights
Cytosine Base Editing Enables Quadruple-Edited Allogeneic CAR-T Cells for T-ALL
07.26.22
Cytosine Base Editing Enables Quadruple-Edited Allogeneic CAR-T Cells for T-ALL
by ASTCT Science Highlights
footer divider

ASTCT

American Society for Transplantation
and Cellular Therapy

330 North Wabash Avenue, Suite 2000
Chicago, IL 60611, USA
Phone: (312) 321-6820
Fax: (312) 673-6733

facebook youtube twitter linkedin
Login
Search